Clinical Trials Logo

Filter by:
NCT ID: NCT02935634 Completed - Clinical trials for Advanced Gastric Cancer

A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer

FRACTION-GC
Start date: November 29, 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the preliminary efficacy, safety, and tolerability of Nivolumab in combination with Ipilimumab or other treatment therapies in participants with advanced gastric cancer.

NCT ID: NCT02935101 Terminated - Cocaine Dependence Clinical Trials

Effects of Glucocorticoids on Craving During Detoxification Treatment of Heroin and/or Stimulants

Goliath
Start date: October 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate whether prednisolone lowers intensity and frequency of craving in heroin-addicted subjects undertaking a detoxification of cocaine and/or heroin.

NCT ID: NCT02934386 Completed - Blood Pressure Clinical Trials

WBPS A Prospective, Method Comparison, Proof of Concept Study

WBPS
Start date: October 2016
Phase: N/A
Study type: Interventional

The study will evaluate the accuracy of BP measurements by a new algorithm to be embedded to the existing CE-marked WinPack device, compared to two reference devices (one oscillometric and one volume-clamp device), in healthy subjects and patients undergoing a standardized physical-activity hypertensive protocol.

NCT ID: NCT02933801 Terminated - Prostate Cancer Clinical Trials

ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.

Start date: March 31, 2017
Phase: Phase 2
Study type: Interventional

The main objective of the trial is to assess impact of maintenance therapy with ODM-201 on radiographic progression-free survival (rPFS) of patients with mCRPC pretreated with novel hormonal agents who have non-progressive disease after chemotherapy with a taxane.

NCT ID: NCT02932839 Completed - Epilepsy Clinical Trials

Investigating the Neuronal Bases of Epilepsy With Micro-electrode Arrays in Candidates for Epilepsy Surgery

IN-MAP
Start date: December 28, 2017
Phase: N/A
Study type: Interventional

This study aims to uncover the neuronal bases of epilepsy by recording the activity of single neurons in the brain of patients with epilepsy who are candidates for assessment with intracranial electroencephalography (EEG). A micro-electrode array will be inserted into the brain in addition to the standard intracranial EEG electrodes for up to 4 weeks.

NCT ID: NCT02932501 Active, not recruiting - Clinical trials for Bisphosphonate-Associated Osteonecrosis of the Jaw

Medication-related Osteonecrosis of the Jaw (MRONJ) Registry

MRONJ
Start date: August 14, 2017
Phase:
Study type: Observational [Patient Registry]

Approximately 500 patients will be included in this patient registry. Data collection includes demographics, clinical data of underlying disease and use of bisphosphonates, denosumab and antiangiogenic drugs , degree and extension of osteonecrosis, osteonecrosis-specific treatment, outcomes and complications within 1 year after treatment.

NCT ID: NCT02931851 Terminated - Extended Family Clinical Trials

Family Information Management in the Intensive Care Unit

ICU-Families
Start date: May 1, 2015
Phase: N/A
Study type: Interventional

Relatives in intensive care units (ICU) are important partners in decision-making in the treatment of critically ill patients and provide a significant resource in the care and recovery of patients. Therefore, a professional, educational intervention targeting these caregivers may have fundamental benefits with little risk. As in other fields, information is searched in the internet, but this unselected information is often overwhelming and of little use in this context. Symptoms of anxiety, stress and depression are common in affected relatives. The majority of family members report some level of anxiety, depression and stress, sometimes even resulting in post-traumatic stress disorder (PTSD). Importantly, an association between lack of information and post-traumatic stress disorder PTSD has been reported. The large number of potentially affected families poses a particular challenge to healthcare and may cause substantial secondary costs to national economy.

NCT ID: NCT02931539 Completed - Clinical trials for Cytomegalovirus (CMV)

Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir

Start date: December 22, 2016
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy of maribavir to investigator-assigned anti-Cytomegalovirus (CMV) therapy in CMV viremia clearance in transplant recipients who are refractory or resistant to prior anti-CMV treatment.

NCT ID: NCT02930928 Completed - Weight-Estimation Clinical Trials

Can Habitus Adapted Length Based Body Weight Estimation be Improved by Adding Further Parameters?

Including MUC
Start date: October 2016
Phase:
Study type: Observational

The purpose of this prospective single center study is to investigate if the accuracy of length based body weight estimation by the already investigated algorithm (CLAWAR) can be improved by adding another parameter. For this study 500 patients are required to collect anonymized data (length, weight, age, mid upperarm circumference and patient habitus by visual estimation) for achieving a power of 80% during statistical analysis. The main hypothesis ist that CLAWAR's accuracy can be improved.

NCT ID: NCT02929329 Completed - Heart Failure Clinical Trials

Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction

GALACTIC-HF
Start date: January 6, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if treatment with omecamtiv mecarbil when added to standard of care is well tolerated and superior to placebo in reducing the risk of cardiovascular death or heart failure events in adults with chronic heart failure with reduced ejection fraction (HFrEF).